Setmelanotide for treating obesity caused by LEPR or POMC deficiency (HST21)
Evidence-based recommendations on setmelanotide (Imcivree) for treating obesity caused by LEPR or POMC deficiency in people 6 years and over
Search results
7 results
-
-
MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)
Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery
-
Thopaz+ portable digital system for managing chest drains (MTG37)
Evidence-based recommendations on Thopaz+ for managing chest drains
-
Peristeen Plus transanal irrigation system for managing bowel dysfunction (MTG36)
Evidence-based recommendations on Peristeen Plus transanal irrigation system for managing bowel dysfunction
-
Sleepio to treat insomnia and insomnia symptoms (MTG70)
Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms
-
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over (HST20)
Evidence-based recommendations on selumetinib (Koselugo) for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over
-
Elosulfase alfa for treating mucopolysaccharidosis type 4A (HST19)
Evidence-based recommendations on elosulfase alfa (Vimizim) for treating mucopolysaccharidosis type 4A in people of all ages